ArticleCPT: pharmacometrics & systems pharmacology2021

Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor.

Ophelia Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.